Table 1.
Clinical information of all patients
| Total (N, %) | 40 | |
| Gender | ||
| Male | 24 (60%) | |
| Female | 16 (40%) | |
| Age | ||
| < 60 | 20 (50%) | |
| ≥ 60 | 20 (50%) | |
| GCB/ABC | ||
| GCB | 20 (50%) | |
| ABC | 20 (50%) | |
| Ann Arbor Staging | ||
| I-II | 7 (17.5%) | |
| III-IV | 33 (82.5%) | |
| IPI Score | Point | |
| Low risk | 0 | 1 (2.5%) |
| 1 | 2 (5%) | |
| Low to medium risk | 2 | 8 (20%) |
| High to medium risk | 3 | 10 (25%) |
| High risk | 4 | 11 (27.5%) |
| 5 | 8 (20%) | |
| NCCN-IPI Score | ||
| Low risk | 0 | 0 (0%) |
| 1 | 3 (7.5%) | |
| Low to medium risk | 2 | 0 (0%) |
| 3 | 9 (22.5%) | |
| High to medium risk | 4 | 8 (20%) |
| 5 | 11 (27.5%) | |
| High risk | 6 | 7 (17.5%) |
| 7 | 2 (5%) | |
| 8 | 0 (0%) | |
| Deauville Score | ||
| 1 | 1 (2.5%) | |
| 2 | 3 (7.5%) | |
| 3 | 8 (20%) | |
| 4 | 11 (27.5%) | |
| 5 | 17 (42.5%) | |
| Affected organs | ||
| 1 | 7 (17.5%) | |
| ≥ 2, < 5 | 21 (52.5%) | |
| ≥ 5, < 10 | 4 (10%) | |
| ≥ 10, < 20 | 8 (20%) |
GCB: germinal center B-cell-like lymphone; ABC: activated B-cell-like lymphoma; IPI Score: international prognostic index score; NCCN-IPI Score: National Comprehensive Cancer Network-International Prognostic Index score.